Literature DB >> 8890079

Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation.

W R Treem1, N Ahsan, G Kastoff, J S Hyams.   

Abstract

Colonic bacterial production of short-chain fatty acids (SCFA) plays an important role in the salvage of unabsorbed carbohydrate and in colonic absorption of electrolytes and water. The objective of this study was to determine whether patients with diarrhea-predominant irritable bowel syndrome (DP-IBS) have a different pattern and rate of fermentation of carbohydrate and fiber to SCFA compared with controls. Fecal homogenates from 10 patients with DP-IBS and 10 age-matched controls were studied. SCFA were measured by gas chromatography in baseline fecal samples and in fecal homogenates in an in vitro anaerobic fermentation system after incubation with no additional substrate, lactulose, potato starch, citrus pectin, and hemicellulose over a 24-hour period. Net SCFA production rates were calculated for the first 6 h of the incubation period. Patients with DP-IBS had a consistently different pattern of less total SCFA, a lower percentage of acetate (p < 0.05), and a higher proportion of n-butyrate (p < 0.05) than controls. In stool homogenates from both controls and DP-IBS patients, lactulose fermentation resulted in the highest rate of SCFA production followed by pectin, starch, and hemicellulose. However, at all time points, the fecal homogenates from controls generated a higher concentration of total SCFA, acetate, and propionate with all substrates tested. SCFA production rates were higher in controls incubated with lactulose, starch, and hemicellulose. The fecal SCFA profile of patients with DP-IBS is characterized by lower concentrations of total SCFA, acetate, and propionate and a higher concentration and percentage of n-butyrate. Fecal flora from these patients produced less SCFA in an in vitro fermentation system in response to incubations with various carbohydrates and fibers. Differences in SCFA production by colonic bacterial flora in patients with DP-IBS may be related to the development of gastrointestinal symptoms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890079     DOI: 10.1097/00005176-199610000-00013

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  53 in total

1.  The role of colonic microbiota in lactose intolerance.

Authors:  Yan Zhong; Marion G Priebe; Roel J Vonk; Cheng-Yu Huang; Jean-Michel Antoine; Tao He; Hermie J M Harmsen; Gjalt W Welling
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

2.  Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations.

Authors:  Junhai Ou; James P DeLany; Ming Zhang; Sumit Sharma; Stephen J D O'Keefe
Journal:  Nutr Cancer       Date:  2011-12-02       Impact factor: 2.900

Review 3.  Microbiota: a novel regulator of pain.

Authors:  Manon Defaye; Sandie Gervason; Christophe Altier; Jean-Yves Berthon; Denis Ardid; Edith Filaire; Frédéric Antonio Carvalho
Journal:  J Neural Transm (Vienna)       Date:  2019-09-24       Impact factor: 3.575

Review 4.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 5.  Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.

Authors:  Michael Camilleri; Joseph H Sellin; Kim E Barrett
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

Review 6.  Collateral damage: microbiota-derived metabolites and immune function in the antibiotic era.

Authors:  Christopher A Lopez; Dawn D Kingsbury; Eric M Velazquez; Andreas J Bäumler
Journal:  Cell Host Microbe       Date:  2014-08-13       Impact factor: 21.023

Review 7.  Intestinal microbiota and its role in irritable bowel syndrome (IBS).

Authors:  Lena Ohman; Magnus Simrén
Journal:  Curr Gastroenterol Rep       Date:  2013-05

8.  Caecal pH is a biomarker of excessive colonic fermentation.

Authors:  Adam D Farmer; Sahar D Mohammed; George E Dukes; S Mark Scott; Anthony R Hobson
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

9.  Melatonin regulation as a possible mechanism for probiotic (VSL#3) in irritable bowel syndrome: a randomized double-blinded placebo study.

Authors:  Reuben K Wong; Cao Yang; Guang-Hui Song; Jennie Wong; Khek-Yu Ho
Journal:  Dig Dis Sci       Date:  2014-08-05       Impact factor: 3.199

10.  The impact of the level of the intestinal short chain Fatty acids in inflammatory bowel disease patients versus healthy subjects.

Authors:  N Huda-Faujan; A S Abdulamir; A B Fatimah; O Muhammad Anas; M Shuhaimi; A M Yazid; Y Y Loong
Journal:  Open Biochem J       Date:  2010-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.